Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

ePHEDrine Sulfate

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71030-003-09 D-1088-2020
Class II · Moderate risk

rocuronium Bromide

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71019-321-05 D-1087-2020
Class II · Moderate risk

nICARdipine HCl

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71019-206-01 D-1082-2020
Class II · Moderate risk

ePHEDrine Sulfate

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71030-003-12 D-1081-2020
Class II · Moderate risk

*Mitomycin 0.04% Ophth DR eye drops

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 67457-0518-05 D-1077-2020
Class II · Moderate risk

*Morphine 2 mg/mL Cassette

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 00409-1134-03 D-1075-2020
Class II · Moderate risk

C-*Vancomycin Opthal 14 mg drops

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 67457-0340-01 D-1074-2020
Class II · Moderate risk

C-*Albumin Eye Drop 10% S

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 44206-0251-05 D-1073-2020
Class II · Moderate risk

Elelyso (taliglucerase alfa)

Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Terminated Sterility / contamination Pfizer Inc. NDC 0069-0106-01 D-0995-2020
Class II · Moderate risk

Cholecalciferol

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0251-3 D-0993-2020
Class II · Moderate risk

Cholecalciferol

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0210-3 D-0992-2020